Moris Angulo
Pediatric Endocrinology · Mineola, NYNPI 1477573269
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,669 of the $72,758 with a category attached, or 60.0%. Novo Nordisk accounts for 79.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $33,832 and has fallen 98.6% since, to $471 in 2025. Among pediatric endocrinology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $568.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$58K
- Ascendis Pharma Endocrinology Inc$13K
- Biomarin Pharmaceutical Inc.$457
- Soleno Therapeutics, Inc.$202
- AbbVie$155
- Neurocrine Biosciences, Inc.$150
- plus $546 from 15 others
Across 42 payments — averaging $7294.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Soleno Therapeutics, Inc.$222K
- Novo Nordisk AS$84K
What the payments were for
- Consulting fees$16,70223%
- Speaking & faculty fees$43,66960%
- Travel & lodging$8,61012%
- Food & beverage$3,0034%
- Education$7741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 75 | $57,898 |
| Ascendis Pharma Endocrinology Inc | 12 | $13,349 |
| Biomarin Pharmaceutical Inc. | 8 | $457 |
| Soleno Therapeutics, Inc. | 3 | $202 |
| AbbVie | 6 | $155 |
| Neurocrine Biosciences, Inc. | 2 | $150 |
| Ipsen Biopharmaceuticals, Inc | 1 | $118 |
| Sanofi-aventis U.S. LLC | 5 | $88 |
| Amphastar Pharmaceuticals, Inc. | 3 | $59 |
| Zealand Pharma US, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Corium, LLC | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Tolmar, Inc. | 1 | $25 |
| Pfizer | 1 | $24 |
| Tolmar Pharmaceuticals, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Norditropin$56,891
- SKYTROFA$13,130
- Diazoxide Choline Controlled Release (DCCR)$163
- CRENESSITY$130
- Bylvay$118
- Palynziq$101
How this compares
$72,758 in reported general payments places this provider in the 95th percentile of 138 pediatric endocrinology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 28 | $487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $29 | $48728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in Mineola
- Paul SaengerMineola$180K
- Robert LevineMineola$33K
- Siham AccachaMineola$23K
- Mariano Castro-MaganaMineola$18K
- Julia Barillas CerritosMineola$6K
- Alicia RomanoSleepy Hollow$157K
- Svetlana TenStaten Island$101K
- Robert RapaportNew York$98K
- Jill BrodskyPoughkeepsie$45K
- Jorge Mejia-CorlettoNorth Babylon$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.